Revolution Medicines Inc (RVMD)

Jan 01, 2026

Revolution Medicines Inc Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Free Popular Stock Picks Selection - earlytimes.in

Jan 01, 2026

Dec 28, 2025

Harbor Capital Advisors Inc. Has $1.01 Million Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 28, 2025

Dec 25, 2025

What sentiment indicators say about Revolution Medicines Inc. stockLong-Term Investment Plans & Access Free Risk Analysis Before You Invest - Bollywood Helpline

Dec 25, 2025

Dec 24, 2025

Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Extending Long-Term Upside Potential - TipRanks

Dec 24, 2025

Dec 22, 2025

Revolution Medicines stock hits all-time high at 81.49 USD By Investing.com - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

Understanding Momentum Shifts in (RVMD) - news.stocktradersdaily.com

Dec 22, 2025

Dec 22, 2025

Revolution Medicines (NASDAQ:RVMD) Hits New 52-Week HighHere's What Happened - MarketBeat

Dec 22, 2025

Dec 22, 2025

Revolution Medicines stock hits all-time high at 81.49 USD - Investing.com

Dec 22, 2025

Dec 21, 2025

How resilient is Revolution Medicines Inc. stock in market downturns2025 Price Targets & Long-Term Growth Stock Strategies - ulpravda.ru

Dec 21, 2025

Dec 19, 2025

Trend Review: Will Revolution Medicines Inc. stock deliver long term returnsMarket Risk Report & Scalable Portfolio Growth Methods - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Why ETFs are accumulating Revolution Medicines Inc. (42Z) stockQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Revolution Medicines Inc. stock valuations compare to rivalsWeekly Profit Recap & Capital Protection Trading Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Revolution Medicines Inc. stock positioned for digital transformationJuly 2025 Earnings & Detailed Earnings Play Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Revolution Medicines Inc. stock positioned well for digital economyMarket Performance Report & Stepwise Trade Execution Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Revolution Medicines Inc. stock weather global recession - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Revolution Medicines Inc. Equity Warrant stock could outperform in 2025Earnings Growth Report & Low Risk High Reward Ideas - Улправда

Dec 19, 2025

Dec 18, 2025

Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 15,394 Shares of Stock - MarketBeat

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (NASDAQ:RVMD) CFO Jack Anders Sells 3,104 Shares - MarketBeat

Dec 18, 2025

Dec 18, 2025

Revolution Medicines Insider Sold Shares Worth $1,182,526, According to a Recent SEC Filing - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (RVMD) General Counsel reports Form 4 stock sale - Stock Titan

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (RVMD) CEO Goldsmith discloses 15,394-share tax-related sale - Stock Titan

Dec 18, 2025

Dec 18, 2025

[Form 4] Revolution Medicines, Inc. Insider Trading Activity - Stock Titan

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (RVMD) COO reports 4,847-share sale under Rule 10b5-1 plan - Stock Titan

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (RVMD) CFO reports 3,104-share sale under 10b5-1 plan - Stock Titan

Dec 18, 2025

Dec 18, 2025

Revolution Medicines Says First Patient Randomized in Phase 3 Pancreatic Cancer Trial - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (RVMD) Launches Key Phase 3 Trial for Pancr - GuruFocus

Dec 18, 2025

Dec 18, 2025

Revolution Medicines randomizes first patient in Rasolute-304 trial - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy - The Manila Times

Dec 18, 2025

Dec 18, 2025

Breakouts Watch: How Revolution Medicines Inc. Equity Warrant stock responds to policy changesJuly 2025 Macro Moves & Real-Time Volume Analysis - Улправда

Dec 18, 2025

Dec 18, 2025

Revolution Medicines (NASDAQ:RVMD) Insider Stephen Michael Kelsey Sells 5,447 Shares - MarketBeat

Dec 18, 2025

Dec 18, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Dec 18, 2025

Dec 14, 2025

HRT Financial LP Increases Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 14, 2025

Dec 14, 2025

Holocene Advisors LP Lowers Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 14, 2025

Dec 13, 2025

Bellevue Group AG Purchases 205,000 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 13, 2025

Dec 12, 2025

Officer Kelsey Files To Sell 5,296 Of Revolution Medicines Inc [RVMD] - TradingView — Track All Markets

Dec 12, 2025

Dec 12, 2025

CFO Anders Files To Sell 3,017 Of Revolution Medicines Inc [RVMD] - TradingView — Track All Markets

Dec 12, 2025

Dec 12, 2025

EMA’s CHMP backs new medicines from Hansoh, Cytokinetics - biocentury.com

Dec 12, 2025

Dec 11, 2025

Avoiding Lag: Real-Time Signals in (RVMD) Movement - news.stocktradersdaily.com

Dec 11, 2025

Dec 11, 2025

FDA Breakthrough Status For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD) - Yahoo Finance

Dec 11, 2025

Dec 09, 2025

Delphia Therapeutics Appoints Steve Kelsey, M.D., To Board - citybiz

Dec 09, 2025

Dec 09, 2025

Revolution Medicines (NASDAQ:RVMD) Reaches New 1-Year HighStill a Buy? - MarketBeat

Dec 09, 2025

Dec 08, 2025

Revolution Medicines, Inc. $RVMD Shares Sold by Hood River Capital Management LLC - MarketBeat

Dec 08, 2025

Dec 08, 2025

New York State Common Retirement Fund Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 08, 2025

Dec 07, 2025

Revolution Medicines (RVMD) up 27.9% since last earnings report: Can it continue? - MSN

Dec 07, 2025

Dec 06, 2025

Norges Bank Invests $62.58 Million in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 06, 2025

Dec 06, 2025

State Board of Administration of Florida Retirement System Acquires 30,128 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 06, 2025

Dec 05, 2025

Revolution Medicines (RVMD) Up 27.9% Since Last Earnings Report: Can It Continue? - sharewise.com

Dec 05, 2025

Dec 05, 2025

Will Revolution Medicines Inc. Equity Warrant stock split attract more investors2025 Retail Activity & Weekly High Momentum Picks - Newser

Dec 05, 2025

Dec 05, 2025

Why Revolution Medicines Inc. Equity Warrant stock is favored by pension fundsJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser

Dec 05, 2025

Dec 05, 2025

Russell Investments Group Ltd. Sells 86,034 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 05, 2025

Dec 04, 2025

Why hedge funds are buying Revolution Medicines Inc. Equity Warrant stock2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Rhumbline Advisers Reduces Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Dec 04, 2025